Fol. Biol. 2013, 59, 204-206
https://doi.org/10.14712/fb2013059050204
RHOA, SEMA3B, and CKAP2 Expression in Leukaemia of Different Types: the Results of a Pilot Experiment
References
1. , S., Fernández-Valerón, P., Espina, C., Lacal, J. C. (2004) Rho GTPases: potential candidates for anticancer therapy. Cancer Lett. 206, 181-191.
<https://doi.org/10.1016/j.canlet.2003.08.035>
2. , C. D., Sung, Y. S., Jeon, S. M., Suh, Y., Yang, H. K., Kim, Y. I., Park, K. H., Choi, J., Ahn, G., Park, J. (2003) Upregulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas. J. Cancer Res. Clin. Oncol. 129, 621-630.
<https://doi.org/10.1007/s00432-003-0484-0>
3. , E. A, Loginov, V. I., Klimov, E. A., Kilosanidze, G., Khodyrev, D. S., Kaganova, N. L., Kazybskaia, T. P., Ermilova, V. D., Gar’kavtseva, R. F., Pronina, I. V., Rud’ko, O. I., Zabarskiĭ, E. R., Sulimova, G. E., Kiselev, L. L. (2006) Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region. Mol. Biol. (Mosk.) 40, 865-877.
<https://doi.org/10.1134/S002689330605013X>
4. , E., Ran, S., Thorpe, P., Minna, J. D. (2004) Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc. Natl. Acad. Sci. USA 101, 11432-11437.
<https://doi.org/10.1073/pnas.0403969101>
5. , S., Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-635.
<https://doi.org/10.1038/nature01148>
6. , Y., Murakumo Y., Ueno, K., Hashimoto, M., Watanabe, T., Shimoyama, Y., Ichihara, M., Takahashi, M. (2004) Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties. Cancer Sci. 95, 815-821.
<https://doi.org/10.1111/j.1349-7006.2004.tb02187.x>
7. , T., Kawakami, S., Koga, F., Arai, G., Takagi, K., Arai, K., Tsujii, T., Yoshida, K. I. (2003) RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int. 91, 234-238.
<https://doi.org/10.1046/j.1464-410X.2003.03063.x>
8. , E. C., Guilluy, C., Burridge, K. (2012) From mechanical force to RhoA activation. Biochemistry 51, 7420-7432.
<https://doi.org/10.1021/bi300758e>
9. , N., Bi, F., Pan, Y., Sun, L., Xue, Y., Shi, Y., Yao, X., Zheng, Y., Fan, D. (2004) Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin. Cancer Res. 10, 6239-6247.
<https://doi.org/10.1158/1078-0432.CCR-04-0242>
10. , L., Deleu, N., Badoual, C., Fraissignes, P., Berger, R., Gaulard, P., Roméo, P. H., Leroy-Viard, K. (1998) Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas. Oncogene 17, 1245-1251.
<https://doi.org/10.1038/sj.onc.1202048>
11. , Y., Bi, F., Liu, N., Xue, Y., Yao, X., Zheng, Y., Fan, D. (2004) Expression of seven main Rho family members in gastric carcinoma. Biochem. Biophys. Res. Commun. 315, 686-691.
<https://doi.org/10.1016/j.bbrc.2004.01.108>
12. , M., Chiarugi, P. (2010) Rac and Rho GTPases in cancer cell motility control. Cell Commun. Signal. 8, 23.
<https://doi.org/10.1186/1478-811X-8-23>
13. , I. V., Loginov, V. I., Prasolov, V. S., Klimov, E. A., Khodyrev, D. S., Kazubskaia, T. P., Gar’kavtseva, R. F., Sulimova, G. E., Braga, E. A. (2009) Alteration of SEMA3B gene expression levels in epithelial tumors. Mol. Biol. (Mosk.) 43, 439-445.
<https://doi.org/10.1134/S002689330903008X>
14. , E. R., Klimov, E. A., Kompaniĭtsev, A. A., Sulimova, G. E. (2002) The structure of the human oncogenesis-associated CKAP2 (LB1) gene. Mol. Biol. (Mosk.) 36, 985-989.
<https://doi.org/10.1023/A:1021625724411>
15. , J., Drabkin, H. A. (2001) The role of semaphorins in lung cancer. Clin. Lung Cancer 3, 145-150.
<https://doi.org/10.3816/CLC.2001.n.026>
16. , K., Lapin, V., Bakal, C., Okada, H., Brown, L., Hirota-Tsuchihara, M., Zaugg, K., Ho, A., Itie-Youten, A., Harris-Brandts, M., Rottapel, R., Richardson, C. D., Benchimol, S., Mak, T. W. (2005) Ckap2 regulates aneuploidy, cell cycling, and cell death in a p53-dependent manner. Cancer Res. 65, 6685-6691.
<https://doi.org/10.1158/0008-5472.CAN-04-4223>
17. , E., Sahai, E., Marshall, C. J. (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4, 67-79.
<https://doi.org/10.1016/S1535-6108(03)00162-4>
18. , U., Terman, J. R. (2006) The semaphorins. Genome Biol. 7, 211.
<https://doi.org/10.1186/gb-2006-7-3-211>
